According to the CDC, over 56 million physician visits were attributed to mental, behavioral or neurodevelopmental disorders as a primary diagnosis.
Mental & behavioral health has become even more of a concern during the COVID-19 pandemic. With this, there has been much discussion & discovery in education, treatments, technology and therapies.
The Center for the Business of Life Sciences at the IU, Kelley School of Business would like to invite you to be a part of this important discussion that impacts so many Americans.
|
| Keynote- On the Cutting Edge of Brain Research William Hetrick, PhD., Professor & Chair, Department of Psychological and Brain Sciences, Indiana University |
| Panel – The Latest Approaches & What’s Next Moderator: Jennifer Kowalski, Vice President, Public Policy Institute, AnthemRob Conley, Chief Science Officer, Neuroscience Development, Eli Lilly and Company Monique Levy, Chief Commercial & Strategy Officer, Woebot Health Minhthy Nguyen, Senior Vice President, Research and Development, Evolve Biosystems Trisha Palencer, Director, Addiction Treatment and Recovery Center, IU Health West Hospital |
| Breakout Sessions Over Lunch (with morning presenters) |
| Fireside Chat – The Effects of the COVID-19 Pandemic Moderator: Kevin Woodhouse, Partner, Ice Miller LLPSusan Coakley, Interim President, Beacon Health Options Geoffrey Fortner, MD, Physician Executive, Community Fairbanks Behavioral Health, Community Health Network Jay Chaudhary, Director, Division of Mental Health and Addiction, Indiana Family and Social Services Administration |
Leave a Reply